« Back to Record
Citation APA

Chan, D. L. H. D., Hayes, A. A., Karfis, I., Conner, A., Furtado O’Mahony, L., Mileva, M., Bernard, E., Roach, P., Marin, G., Pavlakis, N., Schembri, G., Gnanasegaran, G., Marin, C., Vanderlinden, B., Navalkissoor, S., Caplin, M. E., Flamen, P., Toumpanakis, C., & Bailey, D. D. (2023). Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score. British Journal of Cancer, 128(4), 549-555. doi:10.1038/s41416-022-02061-5


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/371019

Chan, D. L. H. D., Hayes, A. A., Karfis, I., Conner, A., Furtado O’Mahony, L., Mileva, M., Bernard, E., Roach, P., Marin, G., Pavlakis, N., Schembri, G., Gnanasegaran, G., Marin, C., Vanderlinden, B., Navalkissoor, S., Caplin, M. E., Flamen, P., Toumpanakis, C., & Bailey, D. D. (2023). Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score. British Journal of Cancer, 128(4), 549-555. doi:10.1038/s41416-022-02061-5